About this trial
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in underserved areas. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this hybrid, Type-1 effectiveness-implementation randomized controlled trial (RCT), the investigators will evaluate the effectiveness and implementation of Peer Activate vs. treatment as usual (TAU) over twelve months.
Eligibility criteria
Qualifiers
None
Disqualifiers
Demonstrating active, unstable or untreated psychiatric symptoms, including mania and/or psychosis that would interfere with study participation
Inability to understand the study and provide informed consent in English
Trial design
Treatments tested in this trial
- Peer-Delivered Behavioral Activation ("Peer Activate")
Treatment groups
Sponsors and collaborators
University of Maryland, College Park
Lead sponsor
University of Maryland, Baltimore
Collaborator
Weill Medical College of Cornell University
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator